Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Kevin Gardner

Tracked across 4 events · 194 articles · First seen May 20, 2026 · Last active Sep 16, 2026

Sentiment
0
Attention
6
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: Kevin Gardner, co-founder of Code and Theory, commented on the acquisition, emphasizing the increased global reach and talent it brings to the network.
Jul 27, 2026 · 7 articles
2 0
Business
Impact: Kevin Gardner is a contact person for investor and media inquiries on behalf of Eupraxia Pharmaceuticals.
May 28, 2026 · 6 articles
6 -10
Regulatory
The United States — United States Senate failed to advance the Digital Asset Market Clarity Act, a landmark cryptocurrency market-structure bill, in a 49-50 procedural vote on September 15, 2026. The bill needed 60 votes…
Impact: The Stifel strategist called passage a long shot given unresolved ethics disputes.
May 20, 2026 · 175 articles
2 0
Business
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, announced that its common shares commenced trading on the Nasdaq Global Select Market, the highest tier of Nasdaq, effective September 8, 2026. The shares previously traded on the…
Impact: Media contact; no direct impact.
Sep 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kevin Gardner live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.